NCT06572982View on ClinicalTrials.gov

Extension Study, Pilot, Compassionate Use of Azacitidine 300 Mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Azacitidine

300 mg Film coated tablets

Sponsors
All Listed Sponsors
lead

Hikma Pharmaceuticals LLC

INDUSTRY

NCT06572982 - Extension Study, Pilot, Compassionate Use of Azacitidine 300 Mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients | Biotech Hunter | Biotech Hunter